NNDM Q1 2026 Earnings Loss Per Share of 034 as Stock Rises Amid Strategic Progress Day One Biopharmaceuticals DAWN Q4 2025 Earnings EPS Miss Reflects RD Spend Amid PreRevenue Status EGAN Q1 2026 Earnings Strong EPS Beat Highlights Profitability Improvement SGMO Q1 2026 Earnings Gene Therapy Focus Drives Stock Higher Despite Deep EPS Miss CACI Q1 2026 Earnings EPS Beat Drives Positive Early Trading THRY Q1 2026 Earnings Massive EPS Beat Lifts Shares as Expense Discipline Shines